Living the PCSK9 adventure: from the identification of a new gene in familial hypercholesterolemia towards a potential new class of anticholesterol drugs.

Abifadel, Marianne; Elbitar, Sandy; El Khoury, Petra; Ghaleb, Youmna; Chémaly, Mélody; Moussalli, Marie-Line; Rabès, Jean-Pierre; Varret, Mathilde; Boileau, Catherine

Abifadel, Marianne; Elbitar, Sandy; El Khoury, Petra; Ghaleb, Youmna; Chémaly, Mélody; Moussalli, Marie-Line; Rabès, Jean-Pierre; Varret, Mathilde; Boileau, Catherine.

Affiliation

Abifadel M; Laboratoire de Biochimie et Thérapies Moléculaires, Faculté de Pharmacie et Pôle Technologie - Santé, Université Saint-Joseph, Beirut, Lebanon, marianne.abi-fadel@inserm.fr.

Curr Atheroscler Rep ; 16(9): 439, 2014 Sep.

Article in En | MEDLINE | ID: mdl-25052769

Subject(s)

Anticholesteremic Agents/therapeutic use; Genetic Predisposition to Disease; Hypercholesterolemia/drug therapy; Hypercholesterolemia/genetics; Mutation/genetics; Proprotein Convertases/genetics; Recovery of Function/genetics; Serine Endopeptidases/genetics; Animals; Humans; Proprotein Convertase 9

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Serine Endopeptidases / Genetic Predisposition to Disease / Recovery of Function / Proprotein Convertases / Hypercholesterolemia / Anticholesteremic Agents / Mutation Type of study: Diagnostic_studies Limits: Animals / Humans Language: En Journal: Curr Atheroscler Rep Journal subject: ANGIOLOGIA Year: 2014 Type: Article

Fulltext

XML

PubMed Links

Search on Google